Terms: = Prostate cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Staging
95 results:
1. Identification of Genes with Rare Loss of Function Variants Associated with Aggressive prostate cancer and Survival.
Saunders EJ; Dadaev T; Brook MN; Wakerell S; Govindasami K; Rageevakumar R; Hussain N; Osborne A; Keating D; Lophatananon A; Muir KR; ; Darst BF; Conti DV; Haiman CA; Antoniou AC; Eeles RA; Kote-Jarai Z
Eur Urol Oncol; 2024 Apr; 7(2):248-257. PubMed ID: 38458890
[TBL] [Abstract] [Full Text] [Related]
2. Development of a prognostic model for long-term survival of young patients with bladder cancer: a retrospective analysis of the SEER Database.
Guo L; Liu L; Liu Y; Yang T; Wang G; Liu J; Li S; Cai J
BMJ Open; 2024 Mar; 14(3):e080092. PubMed ID: 38458812
[TBL] [Abstract] [Full Text] [Related]
3. Unilateral Pelvic Lymph Node Dissection in prostate cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Study That Challenges the Dogma.
Martini A; Wever L; Soeterik TFW; Rakauskas A; Fankhauser CD; Grogg JB; Checcucci E; Amparore D; Haiquel L; Rodriguez-Sanchez L; Ploussard G; Qiang P; Affentranger A; Marquis A; Marra G; Ettala O; Zattoni F; Falagario UG; De Angelis M; Kesch C; Apfelbeck M; Al-Hammouri T; Kretschmer A; Kasivisvanathan V; Preisser F; Lefebvre E; Olivier J; Radtke JP; Briganti A; Montorsi F; Carrieri G; Moro FD; Boström P; Jambor I; Gontero P; Chiu PK; John H; Macek P; Porpiglia F; Hermanns T; van den Bergh RCN; van Basten JA; Gandaglia G; Valerio M
J Urol; 2023 Jul; 210(1):117-127. PubMed ID: 37052480
[TBL] [Abstract] [Full Text] [Related]
4. Artificial intelligence-based model for lymph node metastases detection on whole slide images in bladder cancer: a retrospective, multicentre, diagnostic study.
Wu S; Hong G; Xu A; Zeng H; Chen X; Wang Y; Luo Y; Wu P; Liu C; Jiang N; Dang Q; Yang C; Liu B; Shen R; Chen Z; Liao C; Lin Z; Wang J; Lin T
Lancet Oncol; 2023 Apr; 24(4):360-370. PubMed ID: 36893772
[TBL] [Abstract] [Full Text] [Related]
5. Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsy.
Diamand R; Peltier A; Roche JB; Lievore E; Lacetera V; Chiacchio G; Beatrici V; Mastroianni R; Simone G; Windisch O; Benamran D; Fourcade A; Nguyen TA; Fournier G; Fiard G; Ploussard G; Roumeguère T; Albisinni S
Prostate; 2023 May; 83(6):572-579. PubMed ID: 36705314
[TBL] [Abstract] [Full Text] [Related]
6. Early biomarkers of extracapsular extension of prostate cancer using MRI-derived semantic features.
Guerra A; Alves FC; Maes K; Joniau S; Cassis J; Maio R; Cravo M; Mouriño H
Cancer Imaging; 2022 Dec; 22(1):74. PubMed ID: 36550525
[TBL] [Abstract] [Full Text] [Related]
7. MR-based simplified extraprostatic extension evaluation: comparison of performances of different predictive models.
Schirò S; Milanese G; Maddalo M; Ziglioli F; Maestroni UV; Manna C; Ledda RE; Negrini G; Mastrapasqua F; Cobelli R; Tamburino G; Conti ME; Luceri S; Leo L; Ghetti C; Sverzellati N
Eur Radiol; 2023 Apr; 33(4):2975-2984. PubMed ID: 36512046
[TBL] [Abstract] [Full Text] [Related]
8. Preoperative predictive model of early urinary continence recovery after laparoscopic radical prostatectomy.
Zhang F; Chu H; Hao Y; Yang B; Yan Y; Zhang Y; Liu C; Ma L; Huang Y
World J Urol; 2023 Jan; 41(1):59-65. PubMed ID: 36484818
[TBL] [Abstract] [Full Text] [Related]
9. Modified the 8th AJCC staging system for patients with advanced prostate cancer: a study based on SEER database.
Sun C; Yang D; Zhu J; Zhou Y; Xiang C; Wu S
BMC Urol; 2022 Nov; 22(1):185. PubMed ID: 36384495
[TBL] [Abstract] [Full Text] [Related]
10. Comparison of 18 F-PSMA-1007 PET/CT With 68 Ga-PSMA-11 PET/CT for Initial staging in Intermediate- and High-Risk prostate cancer.
Chandekar KR; Singh H; Kumar R; Kumar S; Kakkar N; Mittal BR; Singh SK
Clin Nucl Med; 2023 Jan; 48(1):e1-e8. PubMed ID: 36240786
[TBL] [Abstract] [Full Text] [Related]
11. A circadian rhythm-related gene signature for predicting relapse risk and immunotherapeutic effect in prostate adenocarcinoma.
Liu J; Tan Z; Yang S; Song X; Li W
Aging (Albany NY); 2022 Sep; 14(17):7170-7185. PubMed ID: 36103249
[TBL] [Abstract] [Full Text] [Related]
12.
Pizzuto DA; Triumbari EKA; Morland D; Boldrini L; Gatta R; Treglia G; Bientinesi R; De Summa M; De Risi M; Caldarella C; Scarciglia E; Totaro A; Annunziata S
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012384
[TBL] [Abstract] [Full Text] [Related]
13. A Web-Based Prediction Model for cancer-Specific Survival of Elderly Patients Undergoing Surgery With prostate cancer: A Population-Based Study.
Zhang Z; Zhanghuang C; Wang J; Mi T; Liu J; Tian X; Jin L; He D
Front Public Health; 2022; 10():935521. PubMed ID: 35903379
[TBL] [Abstract] [Full Text] [Related]
14. Biochemical recurrence related metabolic novel signature associates with immunity and ADT treatment responses in prostate cancer.
Wang X; Lv Z; Xia H; Guo X; Wang J; Wang J; Liu M
Cancer Med; 2023 Jan; 12(1):862-878. PubMed ID: 35681277
[TBL] [Abstract] [Full Text] [Related]
15. Assessment of bone health in patients with prostate cancer using cancer staging computed tomography.
Sato M; Kashii M; Matsukawa A; Mizuno R; Akiyama M; Kamatani T; Kamido S; Ueda N; Nakayama J; Tei N; Yoshikawa H; Miyake O
J Bone Miner Metab; 2022 Jul; 40(4):648-656. PubMed ID: 35546371
[TBL] [Abstract] [Full Text] [Related]
16. Identification and Validation of the Prognostic Impact of Metastatic prostate cancer Phenotypes.
Labe SA; Wang X; Lehrer EJ; Kishan AU; Spratt DE; Lin C; Morgans AK; Ponsky L; Garcia JA; Garrett S; Wang M; Zaorsky NG
Clin Genitourin Cancer; 2022 Aug; 20(4):371-380. PubMed ID: 35383004
[TBL] [Abstract] [Full Text] [Related]
17. Trends in Incidence of Metastatic prostate cancer in the US.
Desai MM; Cacciamani GE; Gill K; Zhang J; Liu L; Abreu A; Gill IS
JAMA Netw Open; 2022 Mar; 5(3):e222246. PubMed ID: 35285916
[TBL] [Abstract] [Full Text] [Related]
18. Development and validation of the 3D U-Net algorithm for segmentation of pelvic lymph nodes on diffusion-weighted images.
Liu X; Sun Z; Han C; Cui Y; Huang J; Wang X; Zhang X; Wang X
BMC Med Imaging; 2021 Nov; 21(1):170. PubMed ID: 34774001
[TBL] [Abstract] [Full Text] [Related]
19. Combined Transfer Learning and Test-Time Augmentation Improves Convolutional Neural Network-Based Semantic Segmentation of prostate cancer from Multi-Parametric MR Images.
Hoar D; Lee PQ; Guida A; Patterson S; Bowen CV; Merrimen J; Wang C; Rendon R; Beyea SD; Clarke SE
Comput Methods Programs Biomed; 2021 Oct; 210():106375. PubMed ID: 34500139
[TBL] [Abstract] [Full Text] [Related]
20. prostate MRI quality: a critical review of the last 5 years and the role of the PI-QUAL score.
Giganti F; Kasivisvanathan V; Kirkham A; Punwani S; Emberton M; Moore CM; Allen C
Br J Radiol; 2022 Mar; 95(1131):20210415. PubMed ID: 34233502
[TBL] [Abstract] [Full Text] [Related]
[Next]
